Clover Health stock has been volatile since the scandal, so here are 3 great alternative investments
The telemedicine market is booming, and Teladoc is leading the way. From fresh IPOs to tech giants, we delve into its top three competitors.
The pandemic and subsequent vaccine news has thrust healthcare stocks into the spotlight — here are our favorites.
Recent reports have stated that tech giant Amazon is planning to expand its telehealth offering to other businesses, which could hurt Teladoc
Telemedicine has had a great year thanks to the pandemic, but with multiple companies releasing vaccines this year, is Teladoc still a good investment?
Multiple vaccines are in the final stages of testing, but will this signal the end for work-from-home stocks, and should investors worry?
The telehealth industry has been booming since the onset of COVID-19, but with a vaccine coming down the tracks, how is Teladoc positioned for growth?
Secular headwinds in the digital health market, the company’s improving sales mix, and its synergistic merger with Livongo all make it look like an attractive opportunity.
We had earnings season from big tech, price hikes, and mergers. Here’s a rundown of what happened on Wall Street yesterday.
In a document filed on Friday, Livongo announced the date its existing shareholders can expect to be paid the special dividend arising from its merger with Teladoc.